Based on the distinctive HCLc immunophenotype, CD19+CD11c+CD103+CD27- tumour cells were purified by flow cytometry and matched CD3+CD19- germline T cells flow-sorted from splenocytes, to ~97% and ~98% purity respectively (Fig 1). This evidence concerns the gene CD19 and neoplasm.